Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.

@article{TomCarneiro2013ResveratrolIP,
  title={Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.},
  author={Joao Tom{\'e}-Carneiro and Manuel Gonz{\'a}lvez and Mar Larrosa and Mar{\'i}a Josefa Ya{\~n}{\'e}z-Gasc{\'o}n and Francisco J. Garc{\'i}a-Almagro and Jos{\'e} A. Ruiz-Ros and Francisco Tom{\'a}s Barber{\'a}n and Mar{\'i}a-Teresa Garc{\'i}a-Conesa and Juan Carlos Esp{\'i}n},
  journal={Annals of the New York Academy of Sciences},
  year={2013},
  volume={1290},
  pages={37-51}
}
Primary prevention of cardiovascular disease (CVD) aims to avoid a first event in subjects that are at risk but have not yet been diagnosed with heart disease. Secondary prevention of CVD aims to avoid new events in patients with established heart disease. Both approaches involve clinical intervention and implementation of healthy lifestyles. The grape and wine polyphenol resveratrol (3,5,4'-trihydroxy-trans-stilbene) has shown cardioprotective benefits in humans. Most of these approaches deal… CONTINUE READING
26 Citations
71 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 71 references

1017–1024

  • M. A. Willrich, M. H. Hirata, R. D. Hirata. 2009. Statin regulation of CYP3A4, 10 CYP3A5expression.Pharmacogenomics
  • 50 Ann. N.Y. Acad. Sci. 1290
  • 2013

2073s–2085s

  • A. Scalbert, G. Williamson. 2000. Dietary intake, bioavailability of polyphenols. J. Nutr. 130
  • 48 Ann. N.Y. Acad. Sci. 1290
  • 2013

Similar Papers

Loading similar papers…